MAGNESIUM OXIDE- magnesium oxide tablet 
Richmond Pharmaceuticals, Inc.

----------

Magnesium Oxide Tablets

ACTIVE INGREDIENT (In each tablet)

Magnesium Oxide 400mg (241.2mg elemental magnesium)

Purpose

Antacid

USES

Relieves: ■ acid indigestion  ■ upset stomach

WARNINGS

Ask a doctor if you have:

kidney disease

Ask a doctor or pharmacist before use if you are:

taking a prescription drug. Antacids may interact with certain prescription drugs.

Do not take

more than 2 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks, except under the advise and supervision of a physician. May have a laxative effect.

If pregnant or breast-feeding,

ask a health professional before use.

Keep Out of Reach of Children.

DIRECTIONS

Antacid Directions:■ take 1 tablet twice a day or as directed by a physician

Magnesium Supplement Directions: ■take 1 to 2 tablets daily or as directed by a physician

OTHER INFORMATION

■ store at room temperature 59°-86° F (15°-30°C) ■ do not use if imprinted safety seal under cap is broken or missing

■ Magnesium content per tablet: 253 mg

INACTIVE INGREDIENTS

 croscarmellose sodium, microcrystalline cellulose, magnesium stearate

Questions or Comments

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
call 804-270-4498, 8.30 am-4.30 pm ET, Monday - Friday

PRINCIPAL DISPLAY PANEL

NDC 54738-973-12- 120 tablets

1

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54738-973
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE400 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Product Characteristics
Colorwhite (Off) Scoreno score
ShapeROUNDSize12mm
FlavorImprint Code AP;136
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:54738-973-12120 in 1 BOTTLE; Type 0: Not a Combination Product02/01/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00102/01/2016
Labeler - Richmond Pharmaceuticals, Inc. (043569607)
Registrant - Advance Pharmaceutical, Inc. (078301063)
Establishment
NameAddressID/FEIBusiness Operations
Advance Pharmaceutical, Inc.078301063manufacture(54738-973)

Revised: 12/2024
Document Id: 2a329845-3f50-540c-e063-6394a90af0a9
Set id: 9119b7f0-3e8a-7be7-e053-2995a90a4634
Version: 13
Effective Time: 20241226
 
Richmond Pharmaceuticals, Inc.